125 related articles for article (PubMed ID: 11869016)
1. Focal neuroendocrine differentiation in non-small cell carcinoma is not predicted by pre-operative routine investigation.
Wallace WA
Eur J Surg Oncol; 2002 Feb; 28(1):63-6. PubMed ID: 11869016
[TBL] [Abstract][Full Text] [Related]
2. Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance.
Ionescu DN; Treaba D; Gilks CB; Leung S; Renouf D; Laskin J; Wood-Baker R; Gown AM
Am J Surg Pathol; 2007 Jan; 31(1):26-32. PubMed ID: 17197916
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S
Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine differentiation in non-small cell lung carcinomas.
Baldi A; Groger AM; Esposito V; Di Marino MP; Ferrara N; Baldi F
In Vivo; 2000; 14(1):109-14. PubMed ID: 10757067
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy.
Howe MC; Chapman A; Kerr K; Dougal M; Anderson H; Hasleton PS
Histopathology; 2005 Feb; 46(2):195-201. PubMed ID: 15693892
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
Lyda MH; Weiss LM
Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
[TBL] [Abstract][Full Text] [Related]
7. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.
Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058
[TBL] [Abstract][Full Text] [Related]
8. Large cell neuroendocrine carcinoma of the lung: a comparison with large cell carcinoma with neuroendocrine morphology and small cell carcinoma.
Peng WX; Sano T; Oyama T; Kawashima O; Nakajima T
Lung Cancer; 2005 Feb; 47(2):225-33. PubMed ID: 15639721
[TBL] [Abstract][Full Text] [Related]
9. [Detection of neuroendocrine differentiation in NSCLC and its clinical significance].
Ouyang N; Chen G; Ding J
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Feb; 24(2):90-2. PubMed ID: 11802946
[TBL] [Abstract][Full Text] [Related]
10. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
[TBL] [Abstract][Full Text] [Related]
11. Mixed small cell carcinomas of the uterine cervix: prognostic impact of focal neuroendocrine differentiation but not of Ki-67 labeling index.
Horn LC; Hentschel B; Bilek K; Richter CE; Einenkel J; Leo C
Ann Diagn Pathol; 2006 Jun; 10(3):140-3. PubMed ID: 16730307
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine differentiation in poorly differentiated lung carcinomas: a light microscopic and immunohistologic study.
Visscher DW; Zarbo RJ; Trojanowski JQ; Sakr W; Crissman JD
Mod Pathol; 1990 Jul; 3(4):508-12. PubMed ID: 2170973
[TBL] [Abstract][Full Text] [Related]
13. Combined large cell neuroendocrine, small cell and squamous carcinomas of the lung with rhabdoid cells.
Chetty R
Pathology; 2000 Aug; 32(3):209-12. PubMed ID: 10968398
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic findings of bronchial brush cytology for pulmonary large cell neuroendocrine carcinomas: comparison with poorly differentiated adenocarcinomas, squamous cell carcinomas, and small cell carcinomas.
Kakinuma H; Mikami T; Iwabuchi K; Yokoyama M; Hattori M; Ohno E; Kuramoto H; Jiang SX; Okayasu I
Cancer; 2003 Aug; 99(4):247-54. PubMed ID: 12925987
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic issues with cytopathologic interpretation of lung neoplasms displaying high-grade basaloid or neuroendocrine morphology.
Maleki Z
Diagn Cytopathol; 2011 Mar; 39(3):159-67. PubMed ID: 21319315
[TBL] [Abstract][Full Text] [Related]
16. Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma.
Matsuki Y; Tanimoto A; Hamada T; Sasaguri Y
Mod Pathol; 2003 Jan; 16(1):72-8. PubMed ID: 12527716
[TBL] [Abstract][Full Text] [Related]
17. Cytological, histological, and immunohistochemical findings of pulmonary carcinomas with basaloid features.
Crapanzano JP; Loukeris K; Borczuk AC; Saqi A
Diagn Cytopathol; 2011 Feb; 39(2):92-100. PubMed ID: 21254456
[TBL] [Abstract][Full Text] [Related]
18. Expression of neuroendocrine markers in non-small cell lung cancer.
Sørhaug S; Steinshamn S; Haaverstad R; Nordrum IS; Martinsen TC; Waldum HL
APMIS; 2007 Feb; 115(2):152-63. PubMed ID: 17295682
[TBL] [Abstract][Full Text] [Related]
19. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival.
Skov BG; Fischer BM; Pappot H
Lung Cancer; 2008 Jan; 59(1):88-94. PubMed ID: 17905466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]